
BMEA Valuation
Biomea Fusion Inc
- Overview
- Forecast
- Valuation
- Earnings
BMEA Relative Valuation
BMEA's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, BMEA is overvalued; if below, it's undervalued.
Historical Valuation
Biomea Fusion Inc (BMEA) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -3.90. The fair price of Biomea Fusion Inc (BMEA) is between to according to relative valuation methord.
Relative Value
Fair Zone
-
Current Price:1.81
Fair
-1.70
PE
1Y
3Y
5Y
Trailing
Forward
-0.70
EV/EBITDA
Biomea Fusion Inc. (BMEA) has a current EV/EBITDA of -0.70. The 5-year average EV/EBITDA is -2.46. The thresholds are as follows: Strongly Undervalued below -11.53, Undervalued between -11.53 and -6.99, Fairly Valued between 2.08 and -6.99, Overvalued between 2.08 and 6.62, and Strongly Overvalued above 6.62. The current Forward EV/EBITDA of -0.70 falls within the Historic Trend Line -Fairly Valued range.
-0.93
EV/EBIT
Biomea Fusion Inc. (BMEA) has a current EV/EBIT of -0.93. The 5-year average EV/EBIT is -2.48. The thresholds are as follows: Strongly Undervalued below -8.73, Undervalued between -8.73 and -5.61, Fairly Valued between 0.64 and -5.61, Overvalued between 0.64 and 3.76, and Strongly Overvalued above 3.76. The current Forward EV/EBIT of -0.93 falls within the Historic Trend Line -Fairly Valued range.
0.00
PS
Biomea Fusion Inc. (BMEA) has a current PS of 0.00. The 5-year average PS is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward PS of 0.00 falls within the Strongly Undervalued range.
-0.97
P/OCF
Biomea Fusion Inc. (BMEA) has a current P/OCF of -0.97. The 5-year average P/OCF is -5.13. The thresholds are as follows: Strongly Undervalued below -16.84, Undervalued between -16.84 and -10.99, Fairly Valued between 0.72 and -10.99, Overvalued between 0.72 and 6.57, and Strongly Overvalued above 6.57. The current Forward P/OCF of -0.97 falls within the Historic Trend Line -Fairly Valued range.
-0.96
P/FCF
Biomea Fusion Inc. (BMEA) has a current P/FCF of -0.96. The 5-year average P/FCF is -4.15. The thresholds are as follows: Strongly Undervalued below -10.99, Undervalued between -10.99 and -7.57, Fairly Valued between -0.72 and -7.57, Overvalued between -0.72 and 2.70, and Strongly Overvalued above 2.70. The current Forward P/FCF of -0.96 falls within the Historic Trend Line -Fairly Valued range.
Biomea Fusion Inc (BMEA) has a current Price-to-Book (P/B) ratio of 3.87. Compared to its 3-year average P/B ratio of 3.35 , the current P/B ratio is approximately 15.47% higher. Relative to its 5-year average P/B ratio of 48.58, the current P/B ratio is about -92.04% higher. Biomea Fusion Inc (BMEA) has a Forward Free Cash Flow (FCF) yield of approximately -92.16%. Compared to its 3-year average FCF yield of -45.73%, the current FCF yield is approximately 101.56% lower. Relative to its 5-year average FCF yield of -35.59% , the current FCF yield is about 158.94% lower.
3.82
P/B
Median3y
3.35
Median5y
48.58
-92.16
FCF Yield
Median3y
-45.73
Median5y
-35.59
Competitors Valuation Multiple
The average P/S ratio for BMEA's competitors is 177.97, providing a benchmark for relative valuation. Biomea Fusion Inc Corp (BMEA) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Performance Decomposition
1Y
3Y
5Y
Market capitalization of BMEA increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of BMEA in the past 1 year is driven by Unknown.
People Also Watch

INMB
INmune Bio Inc
2.160
USD
-3.57%

ZJYL
Jin Medical International Ltd
0.830
USD
-2.35%

SGHT
Sight Sciences Inc
4.230
USD
+0.48%

MPAA
Motorcar Parts of America Inc
14.890
USD
+2.41%

KYTX
Kyverna Therapeutics Inc
3.780
USD
-0.79%

FRGE
Forge Global Holdings Inc
19.150
USD
-3.87%

RMBI
Richmond Mutual Bancorporation Inc
14.710
USD
+1.10%

NBTX
Nanobiotix SA
8.376
USD
-14.96%

MDV
Modiv Industrial Inc
15.110
USD
+0.13%

VTYX
Ventyx Biosciences Inc
2.480
USD
-2.36%
FAQ

Is Biomea Fusion Inc (BMEA) currently overvalued or undervalued?
Biomea Fusion Inc (BMEA) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -3.90. The fair price of Biomea Fusion Inc (BMEA) is between to according to relative valuation methord.

What is Biomea Fusion Inc (BMEA) fair value?

How does BMEA's valuation metrics compare to the industry average?

What is the current P/B ratio for Biomea Fusion Inc (BMEA) as of Aug 27 2025?

What is the current FCF Yield for Biomea Fusion Inc (BMEA) as of Aug 27 2025?

What is the current Forward P/E ratio for Biomea Fusion Inc (BMEA) as of Aug 27 2025?
